dipyridamole has been researched along with Genital Diseases, Male in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Genital Diseases, Male: Pathological processes involving the male reproductive tract (GENITALIA, MALE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mancuso, G | 1 |
| Reggiani, M | 1 |
| Berdondini, RM | 1 |
| Errani, A | 1 |
1 other study available for dipyridamole and Genital Diseases, Male
| Article | Year |
|---|---|
Dipyridamole, as an interferon inducer, versus placebo in the prevention of recurrences of condylomata acuminata after diathermocoagulation.
Topics: Adolescent; Adult; Condylomata Acuminata; Dipyridamole; Electrocoagulation; Genital Diseases, Male; | 1995 |